Formica Granules 1dh 1 Dh Tablet is a Health Canada–registered human drug (DIN 00880752) held by Homeocan Inc., containing Formica Rufa. Health Canada lists its status as Cancelled Post Market (status date 12 Feb 1998). Nexara Health has matched 13 registrations of Formica Rufa across 2 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 00880752 |
|---|---|
| Brand name | Formica Granules 1dh |
| Active ingredient | Formica Rufa |
| Strength | 1 Dh |
| Dosage form | Tablet |
| Route | Oral |
| Company | Homeocan Inc. |
| Status | Cancelled Post Market — 12 Feb 1998 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Formica Rufa registered in other markets
13 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Bestmade Natural Products Formica Rufa | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| Netherlands | Formica rufa | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Formica rufa | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Uitsluitend apotheek of drogist | EU national register | |
| United States | Formica rufa | Boiron | Pellet | listed | FDA NDC | |
| United States | Formica rufa | Boiron | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Formica Rufa worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Formica Granules 1dh (DIN 00880752) marketed in Canada?
No. Health Canada lists DIN 00880752 as Cancelled Post Market as of 12 Feb 1998.
Who holds the Canadian licence for this product?
Homeocan Inc. is the company of record in the Health Canada Drug Product Database.
Is Formica Rufa registered outside Canada?
Yes — Nexara Health has matched 13 registrations in 2 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00880752, status date 1998-02-12; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00880752, status date 1998-02-12; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00880752, status date 1998-02-12; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.